Development and characterization of liposomal formulation of bortezomib

• Asıl Yazarlar: Anil K. Deshantri (Yazar), Josbert M. Metselaar (Yazar), Stavroula Zagkou (Yazar), Gert Storm (Yazar), Sanjay N. Mandhane (Yazar), Marcel H.A.M. Fens (Yazar), Raymond M. Schiffelers (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2019-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Bortezomib is a proteasome inhibitor used for the treatment of multiple myeloma. The poor pharmacokinetic profile and off-target adverse effects provide a strong incentive to develop drug delivery systems for bortezomib. In the past, liposomal encapsulation has been proven to improve the therapeutic...